Cargando…

PLGA nanoparticles delivering CPT-11 combined with focused ultrasound inhibit platinum resistant ovarian cancer

BACKGROUND: Ovarian cancer cells show resistance to platinum drugs treatment, which brings a big challenge to clinical therapeutics. This study aimed to construct effective drug delivering nanoparticles specifically targeting ovarian cancer cell. METHODS: Poly lactic-co-glycolic acid (PLGA) were use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiaogang, Yan, Siqi, Xiao, Fang, Xue, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797841/ https://www.ncbi.nlm.nih.gov/pubmed/35116498 http://dx.doi.org/10.21037/tcr-20-3171

Ejemplares similares

NIR triggered PLGA coated Au-TiO(2) core loaded CPT-11 nanoparticles for human papillary thyroid carcinoma therapy
por: Yu, Tianyu, et al.
Publicado: (2020)

Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles
por: Colzani, Barbara, et al.
Publicado: (2018)

Structural Optimization of Platinum Drugs to Improve the Drug-Loading and Antitumor Efficacy of PLGA Nanoparticles
por: Sokol, Maria B., et al.
Publicado: (2022)

Mechanisms of enhanced antiglioma efficacy of polysorbate 80‐modified paclitaxel‐loaded PLGA nanoparticles by focused ultrasound
por: Li, Yingjia, et al.
Publicado: (2018)

A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.
por: Masuda, N., et al.
Publicado: (1998)

Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy.
por: Tsuda, H., et al.
Publicado: (1994)

Pharmacological Correlation between Total Drug Concentration and Lactones of CPT‐11 and SN‐38 in Patients Treated with CPT‐11
por: Sasaki, Yasutsuna, et al.
Publicado: (1995)

Bioavailability of Orally Delivered Alpha-Tocopherol by Poly(Lactic-Co-Glycolic) Acid (PLGA) Nanoparticles and Chitosan Covered PLGA Nanoparticles in F344 Rats
por: Simon, Lacey C., et al.
Publicado: (2016)

PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors
por: Figueiredo, Marxa, et al.
Publicado: (2012)

Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy
por: Pang, Liang, et al.
Publicado: (2018)

PEGylated PLGA-based phase shift nanodroplets combined with focused ultrasound for blood brain barrier opening in rats
por: Zhang, Xiang, et al.
Publicado: (2017)

Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer
por: Huang, Dongqing, et al.
Publicado: (2021)

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
por: Destache, Christopher J, et al.
Publicado: (2009)

Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer
por: Chang, Chi-Son, et al.
Publicado: (2023)

PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer
por: Risnayanti, Chitra, et al.
Publicado: (2018)

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
por: Lee, Jimin, et al.
Publicado: (2022)

Irinotecan (CPT-11) Treatment Induces Mild Gonadotoxicity
por: Levi, Mattan, et al.
Publicado: (2022)

Effect of CPT‐11 on Lipid Peroxide Level in Mouse Tissues
por: Sadzuka, Yasuyuki, et al.
Publicado: (1997)

Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats
por: Lin, Xiaoxi B., et al.
Publicado: (2012)

High-Intensity Focused Ultrasound Combined With Suction Curettage for the Treatment of Cesarean Scar Pregnancy
por: Zhu, Xiaogang, et al.
Publicado: (2015)

PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
por: Fraguas-Sánchez, Ana I., et al.
Publicado: (2020)

Relationship between Development of Diarrhea and the Concentration of SN‐38, an Active Metabolite of CPT‐11, in the Intestine and the Blood Plasma of Athymic Mice Following Intraperitoneal Administration of CPT‐11
por: Araki, Eiji, et al.
Publicado: (1993)

PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
por: Liang, Gao Feng, et al.
Publicado: (2011)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
por: Della Pepa, Chiara, et al.
Publicado: (2014)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
por: Affatato, Roberta, et al.
Publicado: (2022)

Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer
por: Zhu, Xiaogang, et al.
Publicado: (2020)

TPGS/hyaluronic acid dual-functionalized PLGA nanoparticles delivered through dissolving microneedles for markedly improved chemo-photothermal combined therapy of superficial tumor
por: Peng, Tingting, et al.
Publicado: (2021)

Progress in treatment of small-cell lung cancer: role of CPT-11
por: Saijo, N
Publicado: (2003)

CPT and Superstring
por: Ellis, John R., et al.
Publicado: (1996)

GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
por: Li, Kaichun, et al.
Publicado: (2021)

Biotin-streptavidin-guided two-step pretargeting approach using PLGA for molecular ultrasound imaging and chemotherapy for ovarian cancer
por: Zhou, Hang, et al.
Publicado: (2021)

WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11
por: Xing, Shuqin, et al.
Publicado: (2020)

Co-Delivery of CPT-11 and Panobinostat with Anti-GD2 Antibody Conjugated Immunoliposomes for Targeted Combination Chemotherapy
por: Jose, Gils, et al.
Publicado: (2020)

Cytotoxicity of targeted PLGA nanoparticles: a systematic review
por: Chiu, Hock Ing, et al.
Publicado: (2021)

Effect of PLGA Nanoparticle-Mediated Delivery of miRNA 503 on The Apoptosis of Ovarian Endometriosis Cells
por: Chaichian, Shahla, et al.
Publicado: (2022)

PLGA-Based Nanoparticles in Cancer Treatment
por: Rezvantalab, Sima, et al.
Publicado: (2018)

PEG–PLGA nanoparticles for encapsulating ciprofloxacin
por: Watcharadulyarat, Natsorn, et al.
Publicado: (2023)

Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice
por: Schleifman, Erica B, et al.
Publicado: (2013)

Autologous Skin Fibroblast‐Based PLGA Nanoparticles for Treating Multiorgan Fibrosis
por: Long, Qiang, et al.
Publicado: (2022)

Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound
por: Li, Zhaojun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0jg4dapof0tgie84o094jod2se